[{"indications": "Indications\u00a0in combination with aspirin for the\r\nprevention of atherothrombotic events in patients with acute coronary\r\nsyndrome undergoing percutaneous coronary intervention", "name": "PRASUGREL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs"], "cautions": "Cautions\u00a0patients at increased risk of bleeding\r\n(e.g. from recent trauma, surgery, gastro-intestinal bleeding, or\r\nactive peptic ulcer disease); concomitant\r\nuse of drugs that increase risk of bleeding; discontinue at least 7 days before elective surgery if antiplatelet\r\neffect not desirable; elderly; body-weight less than 60\u00a0kg; history of hypersensitivity reactions to thienopyridines (e.g. clopidogrel); interactions: Appendix 1 (prasugrel)", "side-effects": "Side-effects\u00a0haemorrhage (including gastro-intestinal and intracranial),\r\nhaematoma, haematuria, anaemia, rash; less commonly hypersensitivity reactions including angioedema; rarely thrombocytopenia; also reported thrombotic thrombocytopenic\r\npurpura ", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202499.htm", "doses": ["adult over 18 years, (with\r\naspirin\u2014see notes above) initially 60\u00a0mg as a single dose\r\nthen body-weight over 60\u00a0kg, 10\u00a0mg once daily or body-weight\r\nunder 60\u00a0kg or elderly over 75 years,\r\n5\u00a0mg once daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk"}]